Clinical Trials Directory

Trials / Completed

CompletedNCT05012267

Duration of Prone Position in the Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19).

OptiMal pronE Position LEnghT in Patients With acuTE Respiratory Distress Syndrome Due to COVID-19.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
61 (actual)
Sponsor
Ignacio Saez de la Fuente · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The OMELETTE study is a randomised, controlled, unicentric, open-label study to prove the noninferiority of reduced prone position (PP) sessions (more tan 16 hours) versus prolonged PP (48 hours).

Detailed description

This is a non-comercial, investigator-driven clinical study developed in a single critical care unit. The study is coordinated by the main investigator from Hospital Universitario 12 de Octubre in Madrid; The sponsorship is performed by Dr. Ignacio Sáez (Hospital Universitario 12 de Octubre). The study was planned according to the Good Clinical Practices. Omelette study has been approved by the Ethics Committee. All participating Patients must give informed consent before any study procedure occur.

Conditions

Interventions

TypeNameDescription
OTHER16-hour PPPP according to previous study

Timeline

Start date
2021-03-25
Primary completion
2021-10-27
Completion
2021-10-27
First posted
2021-08-19
Last updated
2021-10-28

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05012267. Inclusion in this directory is not an endorsement.

Duration of Prone Position in the Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19). (NCT05012267) · Clinical Trials Directory